EULAV Asset Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

EULAV Asset Management’s Portfolio ALXN Stock Details ALXN Fund Activity

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-148,000	Closed	-$23.1M	–	244
2020 Q4	$23.1M	Sell	148,000 -74,000	-33%	-$11.6M	0.6%	58
2020 Q3	$25.4M	Buy	222,000 +82,000	+59%	+$9.38M	0.75%	40
2020 Q2	$15.7M	Sell	140,000 -37,000	-21%	-$4.15M	0.51%	65
2020 Q1	$15.9M	Sell	177,000 -65,200	-27%	-$5.85M	0.64%	54
2019 Q4	$26.2M	Sell	242,200 -30,000	-11%	-$3.24M	0.9%	30
2019 Q3	$26.7M	Buy	272,200 +10,000	+4%	+$979K	0.98%	25
2019 Q2	$34.3M	Buy	262,200 +5,000	+2%	+$655K	1.29%	14
2019 Q1	$34.8M	Sell	257,200 -90,800	-26%	-$12.3M	1.43%	12
2018 Q4	$33.9M	Buy	348,000 +38,000	+12%	+$3.7M	1.69%	5
2018 Q3	$43.1M	Sell	310,000 -77,000	-20%	-$10.7M	1.85%	3
2018 Q2	$48M	Buy	387,000 +15,000	+4%	+$1.86M	2.21%	1
2018 Q1	$41.5M	Sell	372,000 -33,000	-8%	-$3.68M	1.98%	3
2017 Q4	$48.4M	Buy	405,000 +18,000	+5%	+$2.15M	2.29%	1
2017 Q3	$54.3M	Hold	387,000	–	–	2.56%	1
2017 Q2	$47.1M	Buy	387,000 +156,000	+68%	+$19M	2.31%	1
2017 Q1	$28M	Buy	231,000 +10,000	+5%	+$1.21M	1.43%	7
2016 Q4	$27M	Sell	221,000 -5,000	-2%	-$612K	1.46%	5
2016 Q3	$27.7M	Buy	226,000 +32,000	+16%	+$3.92M	1.47%	3
2016 Q2	$22.7M	Buy	194,000 +83,000	+75%	+$9.69M	1.24%	6
2016 Q1	$15.5M	Buy	111,000 +34,000	+44%	+$4.73M	0.86%	31
2015 Q4	$14.7M	Hold	77,000	–	–	0.8%	35
2015 Q3	$12M	Sell	77,000 -6,000	-7%	-$938K	0.68%	46
2015 Q2	$15M	Hold	83,000	–	–	0.79%	28
2015 Q1	$14.4M	Hold	83,000	–	–	0.74%	28
2014 Q4	$15.4M	Hold	83,000	–	–	0.83%	17
2014 Q3	$13.8M	Sell	83,000 -11,600	-12%	-$1.92M	0.75%	22
2014 Q2	$14.8M	Hold	94,600	–	–	0.79%	21
2014 Q1	$14.4M	Sell	94,600 -6,000	-6%	-$913K	0.78%	19
2013 Q4	$13.4M	Hold	100,600	–	–	0.73%	28
2013 Q3	$11.7M	Sell	100,600 -24,000	-19%	-$2.79M	0.68%	34
2013 Q2	$11.5M	Buy	+124,600	New	+$11.5M	0.7%	27